IRIS
ALBERTI, Saverio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.191
NA - Nord America 1.901
AS - Asia 1.068
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.177
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.874
IE - Irlanda 1.055
CN - Cina 584
SE - Svezia 541
SG - Singapore 382
IT - Italia 365
PL - Polonia 104
IN - India 38
CA - Canada 26
FR - Francia 26
GB - Regno Unito 22
VN - Vietnam 20
FI - Finlandia 15
BE - Belgio 14
BR - Brasile 13
AT - Austria 12
ID - Indonesia 12
NL - Olanda 12
SA - Arabia Saudita 10
ES - Italia 9
DE - Germania 6
KR - Corea 5
CH - Svizzera 3
IR - Iran 3
EU - Europa 2
HK - Hong Kong 2
PT - Portogallo 2
SM - San Marino 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
EC - Ecuador 1
GE - Georgia 1
IL - Israele 1
IQ - Iraq 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MX - Messico 1
MY - Malesia 1
RU - Federazione Russa 1
TH - Thailandia 1
TR - Turchia 1
UY - Uruguay 1
Totale 5.177
Salva come PNG Salva come JPEG
Città #
Dublin 1.055
Nyköping 479
Beijing 391
Chandler 350
Singapore 296
Princeton 195
Medford 180
Jacksonville 168
Des Moines 146
Messina 106
Warsaw 104
Ann Arbor 61
Dearborn 42
Wilmington 39
Ashburn 34
Jinan 28
Milan 24
Ottawa 23
Hyderabad 22
Boardman 21
Rome 21
Dong Ket 19
Shenyang 19
Houston 18
Nanjing 17
Zhengzhou 14
Brussels 13
Helsinki 13
Naples 13
Jakarta 12
Haikou 11
Pune 11
Taizhou 11
Vienna 11
At Tuwal 10
Guangzhou 10
Tianjin 10
Hangzhou 9
Lanzhou 9
Los Angeles 9
Ningbo 9
Redwood City 9
Chieti 8
Padova 8
San Mateo 8
Hebei 7
Norwalk 7
Catania 6
Falls Church 6
Nanchang 6
Changsha 5
Madrid 5
Novara 5
Woodbridge 5
Chions 4
Grassobbio 4
Jiaxing 4
Palermo 4
Seattle 4
Augusta 3
Barletta 3
Bologna 3
Castellana Grotte 3
Fairfield 3
Granada 3
Lozzo Atestino 3
Misterbianco 3
Prineville 3
Seocho-gu 3
Toronto 3
Washington 3
Aci Catena 2
Cagliari 2
Carmiano 2
Casalnuovo di Napoli 2
Cosenza 2
Covo 2
Florence 2
Fuzhou 2
Leawood 2
Nichelino 2
Oleggio 2
Parma 2
Paullo 2
Ponte di Piave 2
Reggio Calabria 2
San Benedetto del Tronto 2
San Marino 2
Sete Lagoas 2
Spoltore 2
St Louis 2
Strasbourg 2
Venice 2
Verona 2
Zurich 2
Anyang-si 1
Ardabil 1
Baku 1
Bariri 1
Brooklyn 1
Totale 4.227
Salva come PNG Salva come JPEG
Nome #
Anticorpi Anti-Trop-2 ed usi connessi 192
The 150 most important questions in cancer research and clinical oncology series: questions 15-24 : Edited by Chinese Journal of Cancer 67
AHTH-EpCAM AHTHTEJIO HErO IIPHMEHEHHE Russia 65
Abandoning the Notion of Non-Small Cell Lung Cancer 60
Trop-2 is a general cancer growth stimulator through ubiquitous tetraspanin platforms 57
Epigenetic inheritance and the missing heritability 56
Functional inactivation of E-cadherin by Trop-2 drives cancer metastasis 56
Trop-2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis 56
ANASTASI Anna Maria, PETRONZELLI Fiorella, DE SANTIS Rita, ALBERTI Saverio 54
Humanized Anti-Trop-2 Monocolonal Antibodies and Uses Thereof 51
USE OF CIRCULATING SERUM TROP-2 AS NEW TUMOR BIOMARKER - USA 50
HUMANIZED ANTI-TROP-2 MONOCLONAL ANTIBODIES AND USES THEREOF 49
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer 49
T-cell-receptor engagement and tumor ICAM-1 up-regulation are required to by-pass low susceptibility of melanoma cells to autologous CTL-mediated lysis 48
Oncoxx Biotech srl - start-up innovativa 48
ANTI-EPCAM ANTIBODY AND USES THEREOF - Australia 48
ANTI-EPCAM ANTIBODY AND USES THEREOF - South Korea 47
Microscopic tumor foci in axillary lymph nodes may reveal the recurrence dynamics of breast cancer 46
ANTI-EPCAM ANTIBODY AND USES THEREOF China and Hong-Kong 45
null 44
Use of Trop-2 as a predictive marker of response to anti-tumor therapy based on inhibitors of CD9 and Akt and molecules of the tetraspanin signalling network 44
E-cadherin inactivation by Trop-2 drives EMT-less metastatic relapse in triple-negative breast cancer 44
ANTI-EPCAM ANTIBODY AND USES THEREOF 43
ANTI-EPCAM ANTIBODY AND USES THEREOF - Europe 43
Functional inactivation of E-cadherin drives EMT-less metastasis 42
Humanized anti-Trop-2 monoclonal antibodies and uses thereof - US 39
Abstract PD15-04: Trop-2 inactivation of E-cadherin drives triple negative breast cancer relapse 39
Use of circulating serum Trop-2 as new tumor biomarker 38
HUMANIZED ANTI-TROP-2 MONOCLONAL ANTIBODIES AND USES THEREOF - Japan 38
TROP2 is a major determinant of growth and metastatic spreading of human cancer 38
ANTITELO ANTI-EPCAM I NJEGOVE PRIMENE Serbia REPUBLIKA Srbija 37
null 37
Sensori per acidi nucleici 36
Use of Serum Circulating Trop-2 as New Tumor Biomarker 36
The missing folding sequence 36
Humanized Anti-Trop-2 monoclonal antibodies and uses thereof - China 36
Lack of association between BK virus and ependymomas, malignant tumors of pancreatic islets, osteosarcomas and other human tumors 36
Novel domain-targeted anti-Trop-2 monoclonal antibodies to elicit therapeutic synergy against multiple human cancers 36
RE: HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer 35
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and-B breast cancer subtypes 35
Abstract 2851: Trop-2 inactivates E-cadherin for metastatic diffusion in the absence of EMT 35
NUOVE TECNOLOGIE PER ANALISI DI PROTEOMA 34
Oncoxx srl - Start-up innovativa 34
null 34
Native, sequential protein folding via anchored N and C protein termini 33
Trop-1 are conserved growth stimulatory molecules that mark early stages of tumor progression 33
USE OF TROP-2 AS PREDICTIVE MARKER OF RESPONSE TO ANTI-TUMOR THERAPY BASED ON INHIBITORS OF AKT 33
null 32
Trop-2 is a novel PKC-dependent growth-stimulator trans-membrane molecule and a metastasis marker in human cancer 32
TROP2 is a novel, potent stimulator of tumor growth and of metastatic spreading of human cancer 31
A phosphoinositide-binding sequence is shared by PH domain target molecules - A model for the binding of PH domains to proteins 31
Novel anti-Trop-2 monoclonal antibodies with unique binding specificities show therapeutic synergy against most human cancers 30
Anti-Trop-2 monoclonal antibodies and uses thereof in the treatment and diagnosis of tumors - Canada 30
Anti-Trop-2 monoclonal antibodies and uses thereof in the treatment and diagnosis of tumors 30
Transfection and cloning of genes for membrane antigens using the FACS 29
A unique four-hub protein cluster associates to glioblastoma progression 29
(-)-Epigallocatechin-3-gallate (EGCG) post-transcriptionally and post-translationally suppresses the cell proliferative protein TROP2 in human colorectal cancer cells 29
Oligonucleotide sequences that inhibit the expression of chimeric mRNA that control the growth of tumor cells and their use in the medical field 29
null 28
null 28
ANTI-EPCAM ANTIBODY AND USES THEREOF Mexico 28
Overexpression of activated phospholipase Cγ1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy 28
Trop molecules as targets for anti-tumor immunotherapy in man 27
HUMANIZED ANTI-TROP-2 MONOCLONAL ANTIBODIES AND USES THEREOF - Canada 27
null 27
Trop-2 stimulates the growth of human cancer cells through fusion to Cyclin D1 27
Anti-Trop-2 monoclonal antibodies and uses thereof in the treatment and diagnosis of tumors - Europe 27
Regulation of gene expression in choriocarcinoma cell lines 27
Effect of hydrocortisone on the macrophage content, growth and metastasis of transplanted murine tumors 26
Expression of a 38-kD cell-surface glycoprotein in transformed human keratinocyte cell lines, basal cell carcinomas, and epithelial germs 26
Cytoplasmic Trop-1/Ep-CAM overexpression is associated with a favorable outcome in node-positive breast cancer 26
A seven-gene CpG-island methylation panel predicts breast cancer progression 26
Comment on "Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice" 26
A high affinity T cell receptor? 26
null 26
null 26
Anti-Trop-2 monoclonal antibodies and uses thereof in the treatment and diagnosis of tumors - Australia 26
null 26
Abstract 340: The Hu2G10 tumor-selective anti-Trop-2 monoclonal antibody targets the cleaved-activated Trop-2 and shows therapeutic efficacy against multiple human cancers 25
Relationship between large granular lymphocytes and NK-1.2+ cells from normal and poly(inosinic:cytidylic acid) (poly(I:C))-treated mice 25
Transfection into mouse L cells of genes encoding two serologically and functionally distinct bovine class I MHC molecules from a MHC-homozygous animal: Evidence for a second class I locus in cattle 25
DNA methylation prevents transfection of genes for specific surface antigens 25
null 25
null 25
null 25
null 24
Uses of a fusion RNA between CYCLIN D1 and TROP2 in the diagnosis and therapy of tumors 24
Molecular cloning, reconstruction and expression of the gene encoding the alpha-chain of the bovine CD-8 - Definition of three peptide regions conserved across species 24
null 24
Cyclin DI gene contains a cryptic promoter that is functional in human cancer cells 24
Trop-2 activates a dormant Na+/K+-ATPase/PKCα/CD9/ezrin signaling axis to override the basal growth program of cancer cells 24
Molecular Epidemiology of Breast Cancer 24
Metastatic growth of a murine tumor: evidence of dissemination to the lungs in the absence of subcutaneous growth 23
Comparative global gene expression analysis identifies TROP2 as a major determinant of growth and metastatic spreading of human cancer 23
Human height genes and cancer 23
Abstract 328: LCB84, a TROP2-targeted ADC, for treatment of solid tumors that express TROP-2 using the hu2G10 tumor-selective anti-TROP2 monoclonal antibody, a proprietary site-directed conjugation technology and plasma-stable tumor-selective linker chemistry 22
A deterministic code for transcription factor-DNA recognition through computation of binding interfaces 22
Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients 22
USE OF CIRCULATING SERUM TROP-2 AS NEW TUMOR BIOMARKER - EU16797460.9-1118 22
Pharmacogenetic and pharmacogenomic discovery strategies 22
Totale 3.580
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.415
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.415
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020548 0 0 0 0 0 46 12 32 34 121 289 14
2020/2021652 12 10 121 12 259 20 37 44 48 30 23 36
2021/2022790 3 19 1 28 12 8 32 51 31 9 174 422
2022/20232.145 235 140 126 93 77 193 36 91 1.078 10 44 22
2023/2024572 22 56 117 25 48 35 9 88 7 35 8 122
2024/2025560 44 28 48 179 137 124 0 0 0 0 0 0
Totale 5.539